Invitae Akcija

Invitae P/B

Delisted·7. авг 2024.

Однос цене према књижној вредности od Invitae (NVTAQ) na dan 20. авг 2026..

P/B

0,00

Zadnja ažuriranja:

Однос цене према књижној вредности od Invitae je 2026 0,00 . Однос цене према књижној вредности od Invitae je bio 2025 0,00 . Pad je time % niži u odnosu na prethodnu godinu.
Access this data via the Eulerpool API

Invitae Анализа акција

Šta radi Invitae? Invitae Corp is a US-based company specialized in providing genetic tests for the diagnosis, treatment, and prevention of diseases. It was founded in 2010 and is headquartered in San Francisco, California. The company's goal is to lower the cost of genetic testing and increase accessibility for patients through automation and sample pooling methods. Invitae has received significant funding and has expanded its capital through multiple rounds of investments from venture capital firms, totaling nearly half a billion dollars. Its business model focuses on offering genetic tests to a wide range of patient groups, streamlining the testing processes through automation and software optimization. Invitae serves consumers directly, as well as medical professionals, hospitals, health centers, laboratories, and health insurance companies. The company aims to improve disease diagnosis and early detection while promoting long-term patient health. Invitae has broadened its capabilities through strategic acquisitions and partnerships, consolidating genetic data on a single platform. It offers a diverse portfolio of genetic tests for the diagnosis, treatment, and prevention of various diseases, including cancer predisposition, cardiovascular diseases, rare inherited diseases, neurological disorders, and medical genomics. The company also provides genetic counseling and family-oriented diagnosis services, along with an online platform facilitating interactive communication between doctors and patients, enabling the sharing and presentation of genetic information and test results. Invitae is an innovative company that has established itself as a market leader in genetic testing, offering a wide range of products and services facilitated by advanced technologies and data storage solutions. The recent acquisitions and partnerships have expanded Invitae's portfolio, improved its technology platform, and strengthened its position as a provider of high-quality healthcare services, enabling well-informed decision-making for patients and medical professionals. Invitae je jedna od najpopularnijih kompanija na Eulerpool.

Često postavljena pitanja o akciji Invitae

Na Eulerpool-u možete pronaći potpuni historijski razvoj Однос цене према књижној вредности Invitae od 2006. — sa godišnjim vrijednostima, grafikonima i detaljnom analizom.

Однос цене према књижној вредности пореди тржишну цену предузећа са његовом књижном вредношћу. Низак однос може указати на потцењену акцију, док висок однос може сугерисати прецењеност или јаке очекиване раста.

Однос цене и књижне вредности = Цена акције / Књижна вредност по акцији

Da biste proverili Однос цене према књижној вредности's, bitno je da ga uporedite sa konkurentima u istoj industriji i sektoru. Na Eulopoolu, možete pronaći direktna upoređivanja industrije za Однос цене према књижној вредности.

Dobar varira u zavisnosti od industrije i faze razvoja preduzeća. Na Eulopoolu, možete porediti Однос цене према књижној вредности's Invitae sa sličnim preduzećima u sektoru i prosekom industrije da biste proverili da li je atraktivan.

Access this data via the Eulerpool API

Вредновање — Invitae

Sve ključne metrike — Invitae

Раст